Recent advances in the understanding of the induction and regulation of mucosal inflammation

Journal of Gastroenterology

Volumn 38, Issue SUPPL. 15, 2003, Pages 55-58

  Strober, Warren ^a   Fuss, Ivan J ^a   Nakamura, Kazuhiko ^a   Kitani, Atsushi ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokine; Inflammation; Regulatory cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; NAKED DNA; PLASMID DNA; PROTEIN ANTIBODY; STEROID; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; VITAMIN D;

BIOLOGICAL MODEL; COLITIS; CYTOKINE PRODUCTION; DOWN REGULATION; EFFECTOR CELL; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; COLITIS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE;

EID: 0037259157     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
2. Bouma G, Kaushiva A, Strober W. Identification of a genetic region that regulates susceptibility to experimental murine colitis and the interleukin-12 response to LPS. Gastroenterology 2002; 123:554-65.
3. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-90.
4. De Jong YP, Comiskey M, Kalled SL, Mizoguchi E, Flavell RA, Bhan AK, et al. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 2000;119:715-23.
5. Scheerens H, Hessel E, de Waal-Malyeft R, Leach MW, Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/-mice and Rag-2-/-mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol 2001;31:1465-74.
6. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/ signal transducer and activator of transcription (STAT)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 1998;187:1225-34.
7. Ehrhardt RO, Ludviksson BR, Gray B, Neurath M, Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997;158:566-73.
8. Fuss IJ, Marth T, Neurath M, Pearlstein GR, Jain A, Strober W. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 1999;117:1078-88.
9. Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, Strober W. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 2001;22:21-6.
10. ten Hove T, van Montfrans C, Peppelenbosch MP, van Deventer SJ. Infleximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 2002;50:206-11.
11. Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T. Infleximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 2001;121:1145-57.
12. Neurath MF, Fuss I, Kelsall B, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J Exp Med 1996; 183:2605-16.
13. Powrie FJ, Carlino MW, Leach W, Mauze S, Coffman RL. A critical role for transforming growth factor-β but not interleukin-4 in the suppression of T helper type 1-mediated colitis by CD45RBlo CD4+ T cells. J Exp Med 1996;183:2669-74.
14. Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998;18:1-30.
15. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
16. Kawahita K, Misaki Y, Yamauchi M, Tsunekawa S, Setoguchi K, Miyazaki J, et al. Generation of CD4+CD25+ regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 2002;168:4399-405.
17. Shevach EM, Thornton AM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-96.
18. Takashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, et al. Immunologic self tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-80.
19. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+/CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J Exp Med 2001;194:629-44.
20. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190: 995-1004.
21. Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 2002;168:900-8.
22. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific-T-cell response and prevents colitis. Nature 1997;389:737-42.
23. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Maleft R, Roncarolo MG. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001;166:5530-9.
24. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603-16.
25. 2 chain downregulation. J Exp Med 2000;192:41-52.
26. 1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001;108:601-9.
27. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signaling by the interferon-gamma/STAT pathway. Nature 1999;397:710-3.